Comparison between Cyient Ltd. Buyback 2026 and Jagsonpal Pharmaceuticals Buyback 2026.
Cyient Ltd. Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Jagsonpal Pharmaceuticals Buyback 2026 is a Tender Offer proposed to list at NSE, BSE.
| Cyient Ltd. | Jagsonpal Pharmaceuticals Ltd. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Logo |  |  | |||||||||
| Type of Buyback | Tender Offer | Tender Offer | |||||||||
| Listing At | BSE, NSE | NSE, BSE | |||||||||
| Face Value | ₹5 per share | ₹10 per share | |||||||||
| Buyback Price | ₹1125 per share | ₹250 per share | |||||||||
| Issue Size | 64,00,000 shares | 16,00,000 shares | |||||||||
| Issue Size (Amount) | ₹720.00 Crores | ₹40.00 Crores | |||||||||
| Buyback Ratio |
Note:
| ||||||||||
| Registrar | MCS Share Transfer Agent Ltd. | ||||||||||
| Lead Managers | Centrum Capital Ltd. | ||||||||||
| Necessity of the buyback | The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
|
Cyient Ltd. Buyback 2026 and Jagsonpal Pharmaceuticals Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Cyient Ltd. Buyback 2026 Buyback record date is . Jagsonpal Pharmaceuticals Buyback 2026 Buyback record date is May 04, 2026.
| Cyient Ltd. | Jagsonpal Pharmaceuticals Ltd. | |
|---|---|---|
| Record Date | May 04, 2026 | |
| Offer Open Date | May 08, 2026 | |
| Offer Closure Date | May 14, 2026 | |
| Last date for receipt of tender forms | May 15, 2026 | |
| Finalisation of buyback | May 20, 2026 | |
| Last Date for settlment of bids | May 21, 2026 | |
| Last Date for extinguishment of shares | Jun 02, 2026 |
Comparison of Cyient Ltd. Buyback 2026 and Jagsonpal Pharmaceuticals Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
| Cyient Ltd. | Jagsonpal Pharmaceuticals Ltd. | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Company Financials (Restated Consolidated)Cyient Ltd.'s revenue decreased by 1% and profit after tax (PAT) dropped by 12% between the financial year ending with March 31, 2026 and March 31, 2025.
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||
| Stock price at BSE | Stock price at BSE (in preceding 3 months)
| |||||||||||||||||||||||||||||||||||||||||||
| Stock price at NSE | Stock price at NSE (in preceding 3 months)
| |||||||||||||||||||||||||||||||||||||||||||
